More Globe Newswire

View Older Stories View Newer Stories

Nov 4, 2024 07:00AM American Lithium Provides Operations Update
Nov 4, 2024 07:00AM Hatchet Uranium Corp. Signs Agreements with Skyharbour Resources Ltd. on Five Uranium Projects Located Northeast of the Athabasca Basin, Saskatchewan
Nov 4, 2024 07:00AM StorageVault Acquires 2 Stores for $10,500,000
Nov 4, 2024 07:00AM Canadian Premium Sand Inc. Provides Operational Update and Announces Plans for a US Facility
Nov 4, 2024 07:00AM Alta Equipment Group Announces Common Stock Dividend
Nov 4, 2024 07:00AM L’Ordre des CPA du Québec, CPA Ontario, and CPA Canada Reach Agreement on Standard Setting and Education
Nov 4, 2024 07:00AM Dianthus Therapeutics to Participate in Three Upcoming Healthcare Investor Conferences
Nov 4, 2024 07:00AM BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update
Nov 4, 2024 07:00AM TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance
Nov 4, 2024 07:00AM Opthea to Participate in November Investor Conferences
Nov 4, 2024 07:00AM Skye Bioscience Demonstrates Prominent Role of Peripheral CB1 Inhibition and Achieves Significant Weight Loss with Novel CB1-inhibiting Antibody, Nimacimab, in Preclinical Model
Nov 4, 2024 07:00AM Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya
Nov 4, 2024 07:00AM Sono-Tek Announces Share Buyback
Nov 4, 2024 07:00AM EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
Nov 4, 2024 07:00AM Better Choice Company to Host Third Quarter 2024 Financial Results Conference Call on November 12th at 4:30 p.m. ET
Nov 4, 2024 07:00AM CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification
Nov 4, 2024 07:00AM Village Farms International Selected to Testify at Marijuana Rescheduling Hearing
Nov 4, 2024 07:00AM Ascendis Pharma and Novo Nordisk Sign Collaboration for Development and Commercialization of TransCon Technology-based Products in Metabolic and Cardiovascular Diseases
Nov 4, 2024 07:00AM Treace Enters High Volume Osteotomy Market with Nanoplasty™ 3D Minimally Invasive Bunion Correction™ Procedure
Nov 4, 2024 07:00AM Coda Octopus Group Announces Acquisition of Precision Acoustics Limited
Nov 4, 2024 07:00AM Colliers named one of Forbes’ World’s Best Employers 2024
Nov 4, 2024 07:00AM Fractyl Health Presented New Analysis from Pooled Data of Revita® Clinical Studies Demonstrating Durable Weight Loss Maintenance for One Year at ObesityWeek® 2024
Nov 4, 2024 07:00AM Telesat Signs US$39 Million Contract with SatixFy to Develop and Deliver Landing Station Baseband Units for Telesat Lightspeed Network
Nov 4, 2024 07:00AM OTC Markets Group Welcomes Corero Network Security plc to OTCQX
Nov 4, 2024 07:00AM Cullinan Therapeutics to Present Preclinical Data for CLN-978, a CD19-directed T Cell Engager, at ACR Convergence 2024
Nov 4, 2024 07:00AM Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November
Nov 4, 2024 07:00AM Century Therapeutics to Present at Guggenheim’s Inaugural Healthcare Innovation Conference
Nov 4, 2024 07:00AM Oruka Therapeutics to Present at Multiple November Investor Conferences
Nov 4, 2024 07:00AM IGM Biosciences to Present at Three Upcoming Investor Conferences
Nov 4, 2024 07:00AM Memo Therapeutics AG Appoints Frits van Alphen, MD as Chief Development Officer
Nov 4, 2024 07:00AM European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab)
Nov 4, 2024 06:55AM Liquidity Services Announces Fourth Quarter Fiscal Year 2024 Earnings Conference Call
Nov 4, 2024 06:55AM Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025
Nov 4, 2024 06:45AM Castellum, Inc. Announces $11.6 Million Higher Sequential Revenue and Gross Profits for Q3 2024
Nov 4, 2024 06:45AM Brookfield Asset Management Announces Record Third Quarter Results
Nov 4, 2024 06:45AM Aroma Retail Supports Exponential Ecommerce Growth with Descartes Parcel Shipping Solution
Nov 4, 2024 06:45AM Descartes Sets Date to Announce Third Quarter Fiscal 2025 Financial Results
Nov 4, 2024 06:45AM TD LAWSUIT ALERT: A Securities Fraud Class Action has been filed against TD Bank; Investors are Urged to Contact the Firm by December 23 (NYSE:TD)
Nov 4, 2024 06:45AM INVITATION TO DFDS Q3 2024 CONFERENCE CALL
Nov 4, 2024 06:45AM BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update
Nov 4, 2024 06:43AM EW LAWSUIT ALERT: A Securities Fraud Class Action has been filed against Edwards Lifesciences; Investors are Urged to Contact the Firm by December 13 (NYSE:EW)
Nov 4, 2024 06:38AM ADMA INQUIRY ALERT: A Securities Fraud Investigation has been Initiated against ADMA Biologics into the Auditor Resignation; Investors with Losses are Urged to Contact the Firm (Nasdaq:ADMA)
Nov 4, 2024 06:30AM Gran Tierra Energy Inc. Announces Normal Course Issuer Bid and Automatic Share Purchase Plan
Nov 4, 2024 06:30AM Freshpet, Inc. Reports Third Quarter 2024 Financial Results
Nov 4, 2024 06:30AM Atossa Therapeutics Reports Positive KARISMA-Endoxifen Trial Results:
Nov 4, 2024 06:30AM Kraken Robotics Demonstrates New KATFISH Autonomous Launch and Recovery System to Navy Customers
Nov 4, 2024 06:24AM Wereldhave updates on exposure to Blokker
Nov 4, 2024 06:15AM Gran Tierra Energy Inc. Reports Third Quarter 2024 Results and Announces its Sixth Consecutive Ecuador Oil Discovery from the Charapa-B7 Well
Nov 4, 2024 06:14AM Transactions in connection with share buyback programme
Nov 4, 2024 06:05AM MannKind Successfully Completes Phase 1 Trial of Nintedanib DPI for Pulmonary Fibrotic Diseases
View Newer Stories View Older Stories